What the public knows and wants to know about medicines research and development: a survey of the general public in six European countries - Article
Experience of medical research appears to play a key role in increasing public awareness of and future interest in medicines R&D. Some groups may need to be spe...
About 85% of all investments into research are being wasted by asking the wrong questions.
PFMD member Lode Dewulf shares what excites (and worries) him about the current patient engagement landscape
Marylin Metcalf, Senior Director, Benefit Risk Evaluation at GSK: Healthcare is not just about medicine, but also about the way we live.
The series of changes that need to happen in the healthcare system, linked to patient engagement.